Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Status
- RECRUITING
- Phase
- PHASE3
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of GS-0272 in Participants With Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE1
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Obeldesivir in Children and Adolescents With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Leveraging Chatbot to Improve PrEP in the Southern United States
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Teamwork Makes the Dream Work
- Status
- RECRUITING
- Phase
- NA
Study of GS-4528 in Adults With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
- Status
- RECRUITING
- Phase
- PHASE3